| SYS | | r003484 |
|---|
| LBL | | ^^^^^naa^^22^^^^^^^^450^ |
|---|
| 005 | | 20130617114254.6 |
|---|
| 100 | | $a 20001122a m y0sloc0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Thyroid carcinoma: diagnostic and therpeutic approach, genetic background (review) $f A. Lewinski... [et al.] |
|---|
| 215 | | $c Graf, tab. |
|---|
| 320 | | $a Res. angl. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 463 | -1 | $1 001 sllk_un_cat*sg000136_2000_000_002 $1 011 $a 1210-0668 $a 1336-0329 $1 200 1 $a Endocrine regulations $v Roč. 34, č. 2 (2000), s. 99-113 |
|---|
| 541 | 1- | $a Karcinóm štítnej žľazy: diagnostický a terapeutický prístup: vplyv genetický (prehľad) $z slo |
|---|
| 606 | 0- | $a nádory štítnej žľazy $x diagnostika $x terapia $x genetika $2 mesh $3 sllk_un_auth*d013964 |
|---|
| 606 | 0- | $a patológia $x metódy $x trendy $2 mesh $3 sllk_un_auth*d010336 |
|---|
| 606 | 0- | $a genetika $x vybavenie prístrojové $x trendy $2 mesh $3 sllk_un_auth*d005823 |
|---|
| 606 | 0- | $3 sllk_un_auth*d013502 $a chirurgia všeobecná $x metódy $x trendy $2 mesh |
|---|
| 606 | 0- | $a tyroxín $x aplikácia a dávkovanie $x metabolizmus $x farmakokinetika $2 mesh $3 sllk_un_auth*d013974 |
|---|
| 606 | 0- | $3 sllk_un_auth*d002986 $a skúšanie klinické ako téma $x metódy $x trendy $x využitie $2 mesh |
|---|
| 610 | 2- | $a nádory štítnej žľazy |
|---|
| 610 | 2- | $a patológia |
|---|
| 610 | 2- | $a genetika |
|---|
| 610 | 2- | $a L-tyroxín |
|---|
| 610 | 2- | $a chirurgia |
|---|
| 610 | 2- | $a štúdie klinické |
|---|
| 675 | | $a 616.441-006:616.441-089:577.2 $v 1. stred. $z slo |
|---|
| 701 | -1 | $a Lewinski $b A. $3 sllk_un_auth*p0055037 $4 070 $p Department of Thyroidology, Institute of Endocrinology, Medical University of Lodž, Poland |
|---|
| 702 | -1 | $a Ferenc $b T. $3 sllk_un_auth*p0055054 $4 070 $p Department of Biology and Medical Genetics, Military Medical University, Lodž, Poland |
|---|
| 702 | -1 | $a Sporny $b S. $3 sllk_un_auth*p0055058 $4 070 $p Department of Pathomorphology, Chief of Pathomorphology, Medical University of Lodž, Poland |
|---|
| 702 | -1 | $a Jarzab $b B. $3 sllk_un_auth*p0055059 $4 070 $p The Oncology Center, M. Sklodowska-Curie Memorial Institute, Gliwice, Poland |
|---|
| 801 | -0 | $a SK $b BA006 $c 20001122 $g AACR2 |
|---|
